Education and Health Notices




24 AUGUST
NEW ZEALAND GAZETTE
2659

cancel the licence dated 24 September 1998, which was granted under those regulations to Mariana Erueti in respect of Sunshine Preschool (40188), situated at 24 Wellington Street, Hawera.

This notice shall take effect the day after the date of its notification in the New Zealand Gazette.

KATHY PHILLIPS, Senior Manager, National Operations.

go6311

Private Schools Conditional Integration Act 1975

Supplementary Integration Agreements

Pursuant to section 10 of the Private Schools Conditional Integration Act 1975, notice is given that supplementary integration agreements have been signed between the Minister of Education on behalf of Her Majesty the Queen, acting through the Senior Manager, National Operations, Ministry of Education, pursuant to delegated authority, and the proprietors of the following schools:

St Mary’s Catholic School, Rotorua.

St Patrick’s School, Taupo.

The said supplementary integration agreements were executed on the 16th day of August 2000.

Copies of the supplementary integration agreements are available for inspection without charge by any member of the public at the district office of the Ministry of Education, corner of Grey and Bridge Streets, Hamilton.

Dated at Wellington this 16th day of August 2000.

KATHY PHILLIPS, Senior Manager, National Operations.

go6172

Health

Medicines Act 1981

Consent to the Distribution of a New Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Product: Acihexal 250mg

Active Ingredient(s): Aciclovir 250mg

Dosage Form: Powder for infusion

New Zealand Sponsor: Hexal New Zealand Pty Limited

Manufacturer(s): Wasserburger Arzneimittelwerk Dr Madaus GmbH, Wasserburg am Inn, Germany

Product: Acihexal 500mg

Active Ingredient(s): Aciclovir 500mg

Dosage Form: Powder for infusion

New Zealand Sponsor: Hexal New Zealand Pty Limited

Manufacturer(s): Wasserburger Arzneimittelwerk Dr Madaus GmbH, Wasserburg am Inn, Germany

Product: Seretide Accuhaler

Active Ingredient(s): Fluticasone propionate 100μg

Salmetrol xinafoate 72.5μg equivalent to 50μg of salmeterol base

Dosage Form: Powder for inhalation

New Zealand Sponsor: Glaxo Wellcome New Zealand Limited

Manufacturer(s): Glaxo Wellcome Operations, Ware, Hertfordshire, United Kingdom

Product: Seretide Accuhaler

Active Ingredient(s): Fluticasone propionate 250μg

Salmetrol xinafoate 72.5μg equivalent to 50μg of salmeterol base

Dosage Form: Powder for inhalation

New Zealand Sponsor: Glaxo Wellcome New Zealand Limited

Manufacturer(s): Glaxo Wellcome Operations, Ware, Hertfordshire, United Kingdom

Product: Seretide Accuhaler

Active Ingredient(s): Fluticasone propionate 500μg

Salmetrol xinafoate 72.5μg equivalent to 50μg of salmeterol base

Dosage Form: Powder for inhalation

New Zealand Sponsor: Glaxo Wellcome New Zealand Limited

Manufacturer(s): Glaxo Wellcome Operations, Ware, Hertfordshire, United Kingdom

Dated this 18th day of August 2000.

G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).

go6324



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2000, No 107


Gazette.govt.nz PDF NZ Gazette 2000, No 107





✨ LLM interpretation of page content

🎓 Cancellation of Licence for an Early Childhood Centre (continued from previous page)

🎓 Education, Culture & Science
Early Childhood Centre, Licence Cancellation, Sunshine Preschool, Hawera
  • Mariana Erueti, Licence holder for Sunshine Preschool

  • Kathy Phillips, Senior Manager, National Operations

🎓 Supplementary Integration Agreements for Private Schools

🎓 Education, Culture & Science
16 August 2000
Private Schools, Integration Agreements, Catholic Schools, Rotorua, Taupo
  • Kathy Phillips, Senior Manager, National Operations

🏥 Consent to Distribution of New Medicines

🏥 Health & Social Welfare
18 August 2000
Medicines, Aciclovir, Fluticasone, Salmeterol, Pharmaceuticals
  • G. R. Boyd, Chief Advisor, Safety and Regulation